Nebraska Woman Files Lipitor Lawsuit

Elmwood-area Woman Files Lawsuit for Lipitor Injuries

LipitorA woman from Elmwood, Nebraska has filed a lawsuit against Pfizer, alleging that the pharmaceutical manufacturer failed to warn about the dangers of taking Lipitor.

Jodie Ward filed the lawsuit in the middle of April of this year in the US District Court of Nebraska. Although her lawsuit is the first in Nebraska that alleges injuries related to taking Lipitor, a multidistrict litigation (MDL) against the drug has been created in South Carolina. Her case was moved to the multidistrict litigation.

Ward’s South Carolina attorneys stated that, despite knowing about data linking Lipitor to an increased risk for developing Type 2 diabetes, Pfizer promoted the statin as safe and effective for use in people with high cholesterol.

In August 2011, the FDA asked Pfizer to change information on Lipitor’s label after the federal agency reviewed clinical data which linked the drug to Type 2 diabetes. Six months later, the pharmaceutical manufacturer finally added information about the link to their label. However, many plaintiffs allege that the new label still fails to sufficiently warn about the link between Lipitor and Type 2 diabetes.

Pfizer denies the allegations. “Lipitor’s FDA-approved label has at all times provided physicians with accurate information regarding the medicine’s benefits and potential risks. The company refutes the plaintiff’s claims, which involve a medical condition that is highly prevalent in the patient population prescribed statins, and we intend to vigorously defend against the allegations in the complaint,” said Steve Danehy, a senior manager of corporate communications for Pfizer.

Ward took Lipitor to treat her high cholesterol well before the label changed, however. She was prescribed Lipitor in September 2002, and stopped taking the medication in December 2011. She was diagnosed with Type 2 diabetes in 2004.

“As a result, for the rest of her life she must undergo regular testing of her blood glucose levels, adhere to a restrictive diabetic diet, and take medication to control her diabetes,” her attorneys said. They also stated that Pfizer “fraudulently, intentionally, and/or negligently concealed material information, including adverse information, regarding the safety and effectiveness of Lipitor.”

Ward seeks damages for her ongoing medical care and treatment, lost earnings, and pain and suffering.

The Strom Law Firm Is Now Investigating Lipitor Cases

Although many doctors believe that the benefits of statins such as Lipitor outweigh the risks, patients who are otherwise healthy disagree. Type 2 diabetes carries the risk of a wide variety of different side effects, including increased risk of heart and blood vessel disease, nerve damage or neuropathy, kidney damage, osteoporosis, Alzheimer’s disease, skin and mouth conditions, and diabetic macular edema, which can lead to blindness.

On Tuesday, February 18th, the Judicial Panel on Multidistrict Litigation (JPML) reconsidered Lipitor plaintiffs’ request to form a multidistrict litigation against Pfizer, and concluded that there were enough lawsuits to proceed. The MDL will centralize in South Carolina federal court.

The attorneys at the Strom Law Firm are currently investigating claims that taking Lipitor is related to development of Type 2 diabetes. If you or a loved one have taken Lipitor and since developed Type 2 diabetes, you may have a case that could join the South Carolina MDL. You will need the help of a South Carolina defective drug attorney, so contact the Strom Law Firm today for a free consultation regarding the faces of your case. 803.252.4800


Share on facebook
Share on twitter
Share on linkedin

Follow us

Sign Up For Our Newsletter!